ClinicalTrialBatchSummaryBuilder

Clinical Trial Batch Summary Builder

Liquid Biopsy жидкостная биопсия cfDNA ctDNA CTC exosomes NGS qPCR

Utility description: Clinical Trial Batch Summary Builder

Clinical Trial Batch Summary Builder — Clinical Trial Batch Quality Summary

ℹ️ Utility generates consolidated quality report for all Investigational Medicinal Product (IMP) batches within a clinical trial according to ICH E6(R2) GCP and EU CTR 536/2014:
• Data Aggregation: Collection of release, CoA, stability, and deviation data per batch.
• Summary Metrics: Automatic calculation of deviation rate, average assay, QP certification percentage.
• Compliance Check: Verification of release status, stability data currency, and CoA availability.
• Regulatory Readiness: Structured JSON generation for inspections and annual reports.

⚠️ IMPORTANT:
• In EU, no IMP batch can be used without QP certification.
• Expired stability data renders batch unsuitable for patient administration.

Usage:
ClinicalTrialBatchSummaryBuilder.exe → demo mode (console output)
ClinicalTrialBatchSummaryBuilder.exe input.csv output.json → evaluate your data

Input format:
TrialID,Phase,BatchNumber,ProductName,ReleaseStatus,ManufacturingDate,ExpiryDate,Assay_Percent,Impurity_Total_Percent,HasDeviations,DeviationCount,StabilityCurrent,StorageCondition,CoAAvailable,QP_Certified

Example:
TRIAL-001,Phase III,BATCH-A01,mAb-X,Released,2026-01-15,2027-01-15,99.8,0.5,false,0,true,2-8°C,true,true

📍 Scope of Application (Usage Where):
• Clinical Trials: Preparation for sponsor audits and inspections.
• Regulatory Submissions: Inclusion in Annual Safety Report and DSUR.
• QA/QC: Monthly IMP quality review.
• Supply Management: New batch production planning based on trends.

— WHY IS THIS NEEDED?
Clinical trials may involve dozens of batches manufactured at different times.
Without consolidated overview, rapid assessment of overall IMP quality is impossible.
Automated summary saves days of manual work during inspection preparation.
This is critically important for patient safety and regulatory compliance.

⚠️ CRITICAL:
• QP Certification: 100% of EU batches must have QP certificate.
• Stability Data: Expired stability = immediate batch quarantine.
• Deviation Rate: >20% batches with deviations requires process-level CAPA.
• Release Status: Only Released batches may be used in trial.

Key features:
• Automatic aggregation by trial and phase
• Calculation of 6 key quality metrics
• Detection of systemic issues (trends, gaps)
• Regulatory-ready JSON generation
• Compliance with ICH E6(R2) and EU CTR 536/2014

Critical parameters:
• Released Batches: = Total Batches
• Deviation Rate: < 20%
• Avg Assay: 98-102%
• Stability Compliance: 100%
• QP Certification Rate: 100%

💡 Usage tips:
1. Frequency: Generate summary monthly or before each monitoring visit.
2. Integration: Connect to LIMS/eTMF for automatic data collection.
3. Trends: Compare summaries across periods to detect quality degradation.
4. Archiving: Save each summary version as part of Trial Master File.
5. Actions: Initiate CAPA upon gap detection before next shipment.

⚠️ Note: This utility is an aggregation and analysis tool. It does not replace individual QP batch assessment but provides holistic IMP quality picture for management decision making.

input.csv

TrialID,Phase,BatchNumber,ProductName,ReleaseStatus,ManufacturingDate,ExpiryDate,Assay_Percent,Impurity_Total_Percent,HasDeviations,DeviationCount,StabilityCurrent,StorageCondition,CoAAvailable,QP_Certified
TRIAL-2026-001,Phase III,BATCH-A01,mAb-X,Released,2026-01-15,2027-01-15,99.8,0.5,false,0,true,2-8°C,true,true
TRIAL-2026-001,Phase III,BATCH-A02,mAb-X,Released,2026-03-10,2027-03-10,100.2,0.6,true,1,true,2-8°C,true,true
TRIAL-2026-001,Phase III,BATCH-A03,mAb-X,Released,2026-05-20,2027-05-20,99.5,0.4,false,0,true,2-8°C,true,true
TRIAL-2026-002,Phase I,BATCH-B01,ADC-Y,Quarantine,2026-04-01,2026-10-01,97.2,1.8,true,3,false,-20°C,false,false

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of ClinicalTrialBatchSummaryBuilder for Clinical Trial Batch Summary Builder.

Domain limits URS input.csv FS IQ/OQ/PQ

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.

ℹ️ Utility generates consolidated quality report for all Investigational Medicinal Product (IMP) batches within a clinical trial according to ICH E6(R2) GCP and EU CTR 536/2014:
TrialID,Phase,BatchNumber,ProductName,ReleaseStatus,ManufacturingDate,ExpiryDate,Assay_Percent,Impurity_Total_Percent,HasDeviations,DeviationCount,StabilityCurrent,StorageCondition,CoAAvailable,QP_Certified
This is critically important for patient safety and regulatory compliance.
⚠️ CRITICAL:
• QP Certification: 100% of EU batches must have QP certificate.
• Deviation Rate: >20% batches with deviations requires process-level CAPA.
• Compliance with ICH E6(R2) and EU CTR 536/2014
Critical parameters:
• Deviation Rate: < 20%

URS — User Requirements Specification

ID	Requirement	Criticality	Acceptance criterion
URS-001	The utility shall accept an input.csv file for Clinical Trial Batch Summary Builder with headers defined in the data contract.	High	The file is processed without manual header editing.
URS-002	The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.	High	Identical input data, rule version and configuration produce reproducible results.
URS-003	The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.	High	Schema, conversion and range errors are explicitly reported.
URS-004	The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.	High	Each check has PASS/WARNING/FAIL and a clear message.
URS-005	The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.	High	JSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006	The utility shall preserve traceability between batch/sample, input file, applied rules and final status.	High	Output contains identifiers, checked parameters and audit metadata.
URS-007	The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.	Medium	URS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008	The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.	Medium	Documentation states change control and limit-verification expectations.

input.csv contract

#	Field	Type	Sample	Purpose
1	`TrialID`	string / controlled vocabulary	`TRIAL-2026-001`	Controlled input parameter for deterministic QC rules.
2	`Phase`	string / controlled vocabulary	`Phase III`	pH; parameter relevant to stability, compatibility and batch suitability.
3	`BatchNumber`	string / controlled vocabulary	`BATCH-A01`	Batch or lot identifier used for traceability.
4	`ProductName`	string / controlled vocabulary	`mAb-X`	Product or dosage-form name under evaluation.
5	`ReleaseStatus`	string / controlled vocabulary	`Released`	Result/status used in final classification.
6	`ManufacturingDate`	string / controlled vocabulary	`2026-01-15`	Controlled input parameter for deterministic QC rules.
7	`ExpiryDate`	string / controlled vocabulary	`2027-01-15`	Controlled input parameter for deterministic QC rules.
8	`Assay_Percent`	decimal	`99.8`	Controlled input parameter for deterministic QC rules.
9	`Impurity_Total_Percent`	decimal	`0.5`	Purity or impurity profile; key QC parameter.
10	`HasDeviations`	string / controlled vocabulary	`false`	Controlled input parameter for deterministic QC rules.
11	`DeviationCount`	integer / decimal	`0`	Count parameter used for microbiological, particulate or cellular control.
12	`StabilityCurrent`	string / controlled vocabulary	`true`	Controlled input parameter for deterministic QC rules.
13	`StorageCondition`	string / controlled vocabulary	`2-8°C`	Controlled input parameter for deterministic QC rules.
14	`CoAAvailable`	string / controlled vocabulary	`true`	Controlled input parameter for deterministic QC rules.
15	`QP_Certified`	string / controlled vocabulary	`true`	Controlled input parameter for deterministic QC rules.

TrialID,Phase,BatchNumber,ProductName,ReleaseStatus,ManufacturingDate,ExpiryDate,Assay_Percent,Impurity_Total_Percent,HasDeviations,DeviationCount,StabilityCurrent,StorageCondition,CoAAvailable,QP_Certified
TRIAL-2026-001,Phase III,BATCH-A01,mAb-X,Released,2026-01-15,2027-01-15,99.8,0.5,false,0,true,2-8°C,true,true
TRIAL-2026-001,Phase III,BATCH-A02,mAb-X,Released,2026-03-10,2027-03-10,100.2,0.6,true,1,true,2-8°C,true,true
TRIAL-2026-001,Phase III,BATCH-A03,mAb-X,Released,2026-05-20,2027-05-20,99.5,0.4,false,0,true,2-8°C,true,true

Input validation rules

ID	Field	Rule	Criticality
VR-001	`TrialID`	The field shall match an approved dictionary or accepted string representation.	High
VR-002	`Phase`	The field shall match an approved dictionary or accepted string representation.	High
VR-003	`BatchNumber`	The field shall match an approved dictionary or accepted string representation.	High
VR-004	`ProductName`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-005	`ReleaseStatus`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-006	`ManufacturingDate`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-007	`ExpiryDate`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-008	`Assay_Percent`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-009	`Impurity_Total_Percent`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-010	`HasDeviations`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-011	`DeviationCount`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-012	`StabilityCurrent`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-013	`StorageCondition`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-014	`CoAAvailable`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-015	`QP_Certified`	The field shall match an approved dictionary or accepted string representation.	Medium

FS — Functional Specification

ID	Function	Implementation
FS-001	CLI execution	Support execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002	CSV import	Read input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003	Schema validation	Check mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004	Type conversion	Convert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005	Domain rule engine	Apply rules for Clinical Trial Batch Summary Builder, including critical limits from the description and approved specification.
FS-006	Status aggregation	Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007	JSON export	Write output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008	Audit support	Keep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009	Integration contract	Support the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010	Error handling	Return explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "clinicaltrialbatchsummarybuilder",
  "utilityFolder": "ClinicalTrialBatchSummaryBuilder",
  "package": "LiquidBiopsy",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-06-10T00:00:00Z",
  "checks": [
    {
      "parameter": "TrialID",
      "value": "TRIAL-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "Phase",
      "value": "Phase III",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "BatchNumber",
      "value": "BATCH-A01",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "ProductName",
      "value": "mAb-X",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "ReleaseStatus",
      "value": "Released",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "ManufacturingDate",
      "value": "2026-01-15",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "ExpiryDate",
      "value": "2027-01-15",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    },
    {
      "parameter": "Assay_Percent",
      "value": "99.8",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-008"
    },
    {
      "parameter": "Impurity_Total_Percent",
      "value": "0.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-009"
    },
    {
      "parameter": "HasDeviations",
      "value": "false",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-010"
    },
    {
      "parameter": "DeviationCount",
      "value": "0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-011"
    },
    {
      "parameter": "StabilityCurrent",
      "value": "true",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-012"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "ClinicalTrialBatchSummaryBuilder.documentation.html"
  }
}

Traceability matrix

URS	FS	Test	Evidence
URS-001	FS-001, FS-002	OQ-001	Verify execution and import of valid input.csv.
URS-002	FS-005, FS-006	OQ-004	Repeat the same dataset and compare output.json.
URS-003	FS-003, FS-004, FS-010	OQ-002, OQ-003	Verify missing columns and invalid types.
URS-004	FS-005, FS-006	OQ-004, PQ-001	Verify critical deviations on real/boundary data.
URS-005	FS-007, FS-009	OQ-005	Verify JSON schema and downstream-system suitability.
URS-006	FS-008	OQ-006	Verify identifiers and audit metadata.
URS-007	FS-008, FS-010	IQ-001, OQ-007	Verify documentation completeness and control evidence.
URS-008	FS-005, FS-008	PQ-002	Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

ID	Scenario	Expected result
IQ-001	Verify executable, input.csv, documentation and checksum availability.	Delivery set is complete; version is recorded.
OQ-001	Valid sample row from input.csv.	PASS or acceptable WARNING according to rules.
OQ-002	Remove a mandatory CSV column.	Schema error or FAIL with missing-column reference.
OQ-003	Place a non-numeric value into a numeric field.	Type-conversion error with row/field reference.
OQ-004	Set a critical parameter outside the limit.	FAIL and critical finding.
OQ-005	Verify output.json structure.	All mandatory sections are present and JSON is valid.
OQ-006	Verify batch/sample traceability.	Input and result identifiers match.
PQ-001	Verify 3–5 real user batches/samples.	Result is confirmed by QC/QA review.
PQ-002	Verify deviation workflow and manual QA decision.	Utility supports review but does not replace approved decision.

QA/QC and change control

Do not rename columns without updating validator, documentation and test set.
Retain input.csv, output.json, executable version and checksum.
Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Liquid Biopsy QC Suite

QC and pre-analytical control package for liquid biopsy workflows: cfDNA/ctDNA, CTC, EV/exosomes, methylation, NGS/qPCR/ddPCR, sample quality, contamination, sensitivity and reporting checks.

Open